Please login to the form below

Not currently logged in
Email:
Password:

Istodax

This page shows the latest Istodax news and features for those working in and with pharma, biotech and healthcare.

Novartis gets OK for panobinostat in myeloma

Novartis gets OK for panobinostat in myeloma

followed three years later by Celgene's rival CTCL therapy Istodax (romidepsin). .

Latest news

  • Celgene's cancer drug promising in small HIV study Celgene's cancer drug promising in small HIV study

    Lymphoma therapy Istodax shows potential in treating the virus. A cancer drug sold by Celgene could be used to drive HIV from hidden reservoirs within the body so the virus becomes ... Study leader Ole Schmeltz Søgaard from Aarhus University in Denmark

  • FDA gives early green light to Spectrum’s lymphoma drug FDA gives early green light to Spectrum’s lymphoma drug

    Spectrum's Folotyn anti-folate drug (pralatrexate) was cleared in 2009 for use in patients with relapsed or refractory PTCL while Celgene got the nod for its HDAC inhibitor Istodax (romidepsin) ... Spectrum claims Beleodaq has a broader mechanism than

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics